Evotec SE announced that Dr. Craig Johnstone, the company’s Chief Operating Officer, will step down on 31 December 2024. Dr. Johnstone joined E ...

(IN BRIEF) Evotec SE announced that Dr. Craig Johnstone, the company’s Chief Operating Officer, will step down on 31 December 2024. Dr. Johnstone joined Evotec in 2012 and held various leadership ...

EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...

Evotec said Friday that its Chief Operating Officer Craig Johnstone will step down and leave the company in December. The German drug developer said Johnstone's responsibilities will be distributed ...

Evotec (EVO) announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave the company effective December 31. Dr Johnstone joined Evotec in May 2012 as SVP Drug Discovery ...

HAMBURG, GERMANY / ACCESSWIRE / November 29, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig ...

In Europe, the Stoxx Europe 600 fell 0.2% in morning trading. Evotec rose 4.9% and Henkel & Co KGaA Pfd rose 2.9%. On the other hand, Frontline dropped 8.7%, and Grifols lost 6.3%. The FTSE 100 added ...

The company's recent appearance at the Frankfurt Equity Forum left many strategic questions unanswered, highlighting the significant challenges Evotec faces in its future strategic positioning. Fresh ...